# DUMAS (NCT05684276)

> DUMAS: Neo-Adjuvant Immunotherapy for Pancoast Tumors

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05684276
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Fundación GECP
- Conditions: NSCLC; Pancoast Tumor
- Interventions: Carboplatin; Paclitaxel; Nivolumab
- Enrollment: 22
- Primary outcome: Estimate progression-free survival (PFS)

## Preliminary discovery

Commentary in our index that names this trial so far. Final coverage is set when the report is built.

- X threads: 4

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=dumas-nct05684276